Showing results (811-820 of 1,209) with videos related to

Sort By:
Pageof 121
Ethnicity & Disease|March 24, 2025
Exploring Associations between Race/Ethnicity and Glaucoma Prevalence in a Multicenter Brazilian Study: The ELSA-BrasilPatrícia Sena P de G V Protásio, Maria da Conceição Almeida, Marcelo Krieger Maestri, et al.
Brain Sciences|July 27, 2022
Structural Protein Effects Underpinning Cognitive Developmental Delay of the PURA p.Phe233del Mutation Modelled by Artificial Intelligence and the Hybrid Quantum Mechanics-Molecular Mechanics FrameworkJuan Javier López-Rivera, Luna Rodríguez-Salazar, Alejandro Soto-Ospina, et al.
Neuroimage|March 11, 2020
Registration-free analysis of diffusion MRI tractography data across subjects through the human lifespanViviana Siless, Juliet Y Davidow, Jared Nielsen, et al.
Virulence|October 31, 2025
Leishmania amazonensis infection induces IL1β-dependent hyperalgesia, while dampening mechanical allodynia in C57BL/6 miceGustavo G Perez, Emanuelle V de Lima, Leticia S Antonio, et al.
Persoonia|April 3, 2024
The genus Gautieria (Gomphales) in Europe and the Mediterranean Basin: a morphological and phylogenetic taxonomic revisionJ M Vidal, P Cseh, Z Merényi, et al.
Parasites & Vectors|June 2, 2019
Metazoan parasite infracommunities of the dusky flounder (Syacium papillosum) as bioindicators of environmental conditions in the continental shelf of the Yucatan Peninsula, MexicoVíctor M Vidal-Martínez, Iván Velázquez-Abunader, Oscar Arturo Centeno-Chalé, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 18, 2022
A 60 MeV proton beam-line dedicated to research and development programsP Hofverberg, M Antunes, C Armando, et al.
Nature Immunology|November 24, 2015
Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cellsClaudia U Duerr, Connor D A McCarthy, Barbara C Mindt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockadeP Nuciforo, T Pascual, J Cortés, et al.
NPJ Precision Oncology|March 20, 2021
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancerG Griguolo, G Serna, T Pascual, et al.
Pageof 121